Specific decrease of anti-pseudomonal IgA after anti-pseudomonal therapy in cystic fibrosis
- PMID: 7720747
- DOI: 10.1007/BF01991922
Specific decrease of anti-pseudomonal IgA after anti-pseudomonal therapy in cystic fibrosis
Abstract
In patients with cystic fibrosis (CF) and chronic colonisation with Pseudomonas aeruginosa, specific anti-pseudomonal IgG and IgA, as well as serum immunoreactive protein C, WBC and differential count, ESR, pulmonary function and chest radiograph score were determined before and after a 2 week intravenous course of anti-pseudomonal antibiotics in 32 cases of acute exacerbation of pulmonary infection. Specific anti-pseudomonal IgA but not specific anti-pseudomonal IgG decreased significantly after treatment. Log of anti-pseudomonal IgA but not log anti-pseudomonal IgG correlated well with disease severity as assessed by the Brasfield chest radiograph score (r 0.57), forced expiratory volume in 1 s (r 0.6) as well as C-reactive protein (r 0.62).
Conclusion: Specific anti-pseudomonal IgA may be a better parameter than specific IgG in the follow up of lung infection in patients with CF, probably because it more closely reflects ongoing endobronchial infection, the major pathology in CF lungs.
Similar articles
-
Serum IgA and IgG subclasses during treatment for acute respiratory exacerbation in cystic fibrosis: analysis of patients colonised with mucoid or non-mucoid strains of pseudomonas aeruginosa.Immunol Invest. 1994 Jan;23(1):1-13. doi: 10.3109/08820139409063428. Immunol Invest. 1994. PMID: 8144195
-
Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.J Clin Microbiol. 1990 Apr;28(4):747-55. doi: 10.1128/jcm.28.4.747-755.1990. J Clin Microbiol. 1990. PMID: 2110181 Free PMC article.
-
Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis.Arch Dis Child. 1990 Mar;65(3):259-63. doi: 10.1136/adc.65.3.259. Arch Dis Child. 1990. PMID: 2110441 Free PMC article.
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary.Pediatr Pulmonol. 2013 Jun;48(6):525-37. doi: 10.1002/ppul.22757. Epub 2013 Jan 28. Pediatr Pulmonol. 2013. PMID: 23359557 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous